✦ LIBER ✦

Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study

✍ Scribed by Pasquale Comella; Nicola Panza; Luigi Manzione; Giuseppe De Cataldis; Riccardo Cioffi; Luigi Maiorino; Vito Lorusso; Alfredo Lamberti; Enrico Micillo; Michele Natale; Domenico Bilancia; Gianpaolo Nicolella; Angelo Di Nota; Sergio Mancarella; Giuseppe Frasci; Giuseppe Comella

Book ID: 119935441
Publisher: CIG Media Group, LP.
Year: 2000
Tongue: English
Weight: 440 KB
Volume: 1
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2000.n.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Interim Analysis of a Pha

Commentary on “Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer (NSCLC)”

✍ Gregory A. Masters 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 350 KB

Cisplatin-gemcitabine, vs. cisplatin-gem

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

✍ Comella, P; Frasci, G; Panza, N; Nicolella, G; Manzione, L; De Cataldis, G; Ciof 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Cisplatin-gemcitabine-vinorelbine (PGV)

Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial

✍ P. Comella; N. Panza; G.P. Nicolella; L. Manzione; V. Lorusso; R. Cioffi; G. Dec 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Cisplatin/gemcitabine (CG) vs cisplatin/

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung cancer. Interim analysis of a Spanish Lung Cancer Group (SLCG) phase III trial

✍ Alberola, V; Camps, C; Provencio, M; Isla, D; Vadell, C; Pérez Carrión, R; Gonzá 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Gemcitabine, vinorelbine and cisplatin c

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; H Dürk; M Kneba; N Dickgreber; T Welte; T Müller; J Scholtze; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Cisplatin/gemcitabine (CG) vs cisplatin/

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (gv/iv) in advanced non-small cell lung cancer (NSCLC): final results of a Spanish lung cancer group phase III trial (GEPC/98-02)

✍ C. Camps; V. Alberola; M. Provencio; D. Isla; R. Rosell; C. Vadell; I. Bover; A. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB